In this study, we demonstrated that GSTM3TV2 acted as a key ceRNA to decrease gemcitabine-induced cytotoxicity in vitro and in vivo, which provided additional evidence for understanding lncRNA in chemoresistance of pancreatic cancer. This evidence concerns the gene GSTM3 and familial pancreatic carcinoma.